
INHALE
@HAP_Diagnostics
Followers
409
Following
197
Media
57
Statuses
329
NIHR-funded research programme evaluating the use of rapid molecular diagnostics for HAP/VAP in Critical Care. https://t.co/3tMP0IqQRp
London
Joined December 2016
'INHALE Poem II – A slight diversion’ shares the journey of INHALE, describing its hopes, challenges and implications of the research. This poem was written and performed by Amander Wellings, of the INHALE Patient, Carer and Public Involvement (PPI) group.
www.youtube.com
The INHALE study tested whether new, faster ways of finding the cause of pneumonia could increase the speed at which patients receive the correct antibiotic....
0
1
0
4/4 "Guidelines vs mindlines: A qualitative investigation of how clinicians' beliefs influence the application of rapid molecular diagnostics in intensive care", published in Antimicrobial Agents and Chemotherapy is now available.
journals.asm.org
Rapid molecular diagnostic tests for pathogens and resistance genes may improve antibiotic-prescribing decisions and stewardship. However, clinicians’ desire to protect their patients with antibiot...
0
0
0
RT @Beat_AMR_Bugs: 1/2 The INHALE WP3 randomised trial provides multi-centre evidence that rapid syndromic PCR, delivered at the point-of c….
link.springer.com
Intensive Care Medicine - INHALE investigated the impact of seeking pathogens by PCR on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia (HAP...
0
4
0
We’re expanding our reach!. Follow us on:.Bluesky: @ LinkedIn: INHALE trial (. For all of the latest news from INHALE.
www.linkedin.com
INHALE Trial | 4 followers on LinkedIn. NIHR-Funded research programme evaluating the use of rapid molecular diagnostics for HAP/VAP in Critical Care. | The INHALE study investigates the issue of...
0
1
1
RT @Beat_AMR_Bugs: Flexible job opportunity! We're seeking a research associate to work on the @HAP_Diagnostics project. Mainly analyses &….
0
4
0
RT @DrSJStewart: Great to be in sunny (but very windy) Cascais for #EHPS2024. Looking forward to presenting some of our work from @HAP_Diag….
0
2
0
Our latest paper - exploring clinician prescribing behaviour in icu during the covid pandemic.
ICU doctors see potential in molecular tests for better antibiotic use, but worry about stopping broad-spectrum antibiotics for critically ill patients.Read the #OpenAccess article by @DrSJStewart et al:.@Beat_AMR_Bugs @OUPMedicine @OxfordJournals #JACNews.
0
0
2
RT @DrSJStewart: Excited to share our latest paper from the INHALE research programme @HAP_Diagnostics exploring prescribers' attitudes tow….
0
2
0
Fascinating results from Dagfunn Markussen demonstrating that “high quality” and “low quality” respiratory samples showed no difference in detection of common pneumonia pathogens in CAP patients. #eccmid2023
0
1
2
RT @HAP_Diagnostics: Don’t miss INHALE RCT trial results of POCT multiplex pneumonia PCR presented by @Beat_AMR_Bugs today at 16:15 in Ha….
0
4
0
Don’t miss INHALE RCT trial results of POCT multiplex pneumonia PCR presented by @Beat_AMR_Bugs today at 16:15 in Hall P. #ECCMID2023.
0
4
4
Rob Horne: One major finding of our behaviour work was that clinicians do not sufficiently consider the immediate harms of broad-spectrum antibiotics. Future antibiotic stewardship interventions should focus on this. #eccmid2023
0
1
5
RT @DrSJStewart: 80% of clinicians believed molecular diagnostics but concerns such as fears of patient deterioration drove non-adherence t….
0
2
0
Our #healthec analysis shows ICU costs for participants in PCR intervention arm were lower in all scenarios analysed, Those in the @BioFireDX Pneumonia Panel arm had an average saving of £9,940 for the ICU stay.
We’re presenting our alongside trial health economics and behaviour work today! Come and see us in sector C row 7 : P1701 and P1710 @DrSJStewart @NorwichCTU @Beat_AMR_Bugs
0
1
6
We’re presenting our alongside trial health economics and behaviour work today! Come and see us in sector C row 7 : P1701 and P1710 @DrSJStewart @NorwichCTU @Beat_AMR_Bugs
0
3
4